Valeo Financial Advisors LLC Has $599,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Valeo Financial Advisors LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,668 shares of the company’s stock after acquiring an additional 544 shares during the quarter. Valeo Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $599,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Mesirow Financial Investment Management Inc. grew its stake in GE HealthCare Technologies by 39.6% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock valued at $383,000 after buying an additional 1,159 shares during the last quarter. Cathy Pareto & Associates Inc. acquired a new position in GE HealthCare Technologies in the 4th quarter valued at $670,000. LMR Partners LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth $7,387,000. Principal Financial Group Inc. grew its position in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after purchasing an additional 19,010 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in GE HealthCare Technologies in the 3rd quarter worth $1,396,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 1.4 %

Shares of NASDAQ GEHC opened at $92.21 on Monday. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a market cap of $42.13 billion, a PE ratio of 25.33, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a 50-day moving average of $84.03 and a two-hundred day moving average of $85.54.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were given a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date was Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Analyst Ratings Changes

GEHC has been the topic of several research analyst reports. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.